A strong goal-oriented and results-driven scientific leader with strategic vision and passion for cutting edge science that will bring innovative treatments to patients. Over 15 years of drug discovery experience in small, mid-size and large global pharma companies. Versatile background and experience from discovery to clinical translation in oncology including cancer immunotherapy. Experience in translational research including biomarker development and patient selection strategies. Proven track record for driving discovery and development of small and large molecule clinical candidates. Devise an efficient and effective approach for the evaluation and/or validation of new targets in oncology and immunotherapy and develop a cohesive cancer biology strategy. Develop collaborative plans to enhance company visibility and capacity across academia, industry partners and key opinion leaders.Respected people manager and a leader who builds and fosters collaborative, productive teams and who is adept at communicating across all levels.

Associate Director, Oncology Pharmacology @ From September 2012 to Present (3 years 4 months) Group Leader Oncology Pharmacology @ From 2010 to Present (5 years)

Shailaja Kasibhatla is skilled in: Cancer, Drug Discovery, Oncology, Pharmacology, Assay Development, Drug Development, In Vitro, Cell Biology, Cell, Lifesciences, Biotechnology, Immunology, Molecular Biology, In Vivo, Biomarkers, High Throughput Screening, Biochemistry, Cell Culture